UNSPSC 85813305: Introduction of other therapeutic substance into skin and mucous membranes, external approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other therapeutic substance into skin and mucous membranes, external approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E00XGC

UNSPSC 85813305 Introduction of other therapeutic substance into skin and mucous membranes, external approach (Commodity) shows little market activity under its nominal scope; the recent opportunities posted under this code do not reflect topical or external therapeutic applications but instead span a broad range of occupational health, wellness, medical staffing, and specialty care services typical of state and local healthcare procurement more generally. State and local issuers soliciting under this code include county health systems (Santa Clara, Brevard, Sarasota), county sheriffs' offices (Boulder, Seminole), city health departments (Phoenix, Ocala, Atlanta), county behavioral health divisions (Ventura, Santa Clara), state health agencies (Nevada Health Authority, Colorado Department of Human Services, Texas HHSC, New Jersey Department of Health), school districts (Parkway), cooperative purchasing consortia (Sourcewell), and special-purpose health authorities (Inland Empire Health Plan). The work actually being bought spans virtual urgent care delivery, medical director services for EMS systems, emergency medical technician staffing, cancer screening and registry services, ophthalmology and retinal imaging, occupational health exams and drug testing, behavioral health crisis stabilization, opioid use disorder treatment and recovery services, nursing home placement for specialized populations, histology lab analysis, wellness programming, and various forms of clinical staffing and evaluation services—none of which align with the code's stated focus on external application of therapeutic substances.

Recent activity concentrates in California (San Mateo County, Inland Empire, Los Alamos County), Nevada (Nevada Health Authority), Colorado (Denver-based state procurement), Texas (Austin-based state HHSC facilities), and scattered county and municipal procurements across Arizona, Florida, Georgia, Illinois, Kansas, Missouri, New York, and Oregon. Representative recent opportunities include the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly operations across statewide service areas due December 10, 2026 (fixed monthly capitation model serving dual-eligible and non-dual seniors); San Mateo County's RFP for cancer registry services for San Mateo Medical Center due November 6, 2026 (casefinding, abstraction, and submission with local business preferences); Seminole County's RFP for EMS Medical Director services due August 5, 2026 (10-year emergency medicine experience required, conflict-of-interest screen mandating independence from receiving hospitals); and the City of Phoenix's five-year cancer screening contract opportunity due February 2, 2026 (14,000-employee population, maximum annual value $3.5 million, DBE participation mandated). The code appears to be a misclassification artifact in the posting systems rather than a true procurement category for the stated therapeutic application, making activity evaluation under its nominal scope unreliable for business development purposes.